Douglas Bryant, Chairman and Chief Executive Officer of QuidelOrtho Corporation, designs the company’s long-term vision and strategy. Mr. Bryant has more than three decades of industry experience, undertaking multiple global leadership roles in the diagnostics space. Mr. Bryant served as President and Chief Executive Officer of Quidel Corp. from March 2009 to May 2022, where he orchestrated the company’s transformative response to the COVID-19 pandemic and complementary acquisition of Ortho Clinical Diagnostics. Prior to joining Quidel, Mr. Bryant served as Executive Vice President and Chief Operating Officer at Luminex Corporation, managing its Bioscience Group, Luminex Molecular Diagnostics (Toronto), manufacturing, R&D, technical operations, and commercial operations. From 1983 to 2007, he held various worldwide commercial operations positions with Abbott Laboratories, including, among others: Vice President of Abbott Vascular for Asia/Japan, Vice President of Abbott Molecular Global Commercial Operations, and Vice President of Abbott Diagnostics Global Commercial Operations. Earlier in his career with Abbott, Mr. Bryant was Vice President of Diagnostic Operations in Europe, the Middle East and Africa, and Vice President of Diagnostic Operations in the Asia Pacific. Mr. Bryant holds a B.A. in Economics from the University of California at Davis.

Source: QuidelOrtho Corporation on 06/15/2022